drugset / Trial / NCT05528120

Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects

NCT05528120 ↗

Phase 1 Completed 16 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedCrossoverOpen-labelTreatment

Summary

This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate pharmacokinetics of a single oral dose of VC004 capsules under fasting and fed conditions in healthy subjects.

Timeline

Start
2022-10-20
Primary completion
2022-10-28
Completion
2022-11-23

Drugs

EvaluationDrugModalityDoseRoute
Subject VC004 Unknown — Oral